Price movement over the last 24 hours
Aptos vs Enzyme — how do they compare? Aptos trades at Rp11,181 (market cap Rp9,38T, Rp1,3T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Aptos is far larger — about 69932.2× Enzyme's market cap, and Aptos's supply is capped (833M / 2,1B APT (40%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 31 Days and Enzyme for 28 Days on average.
| APT | MLN | |
|---|---|---|
Market Cap | Rp9,38T | Rp134,13M |
Volume (24h) | Rp1,3T | Rp104,56M |
Circulating Supply | 833M / 2,1B APT (40%) | 3,3M MLN |
Typical Hold Time | 31 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Aptos trades at Rp11,163 with a market cap of Rp9.38T, showing neutral technical signals overall. The asset is currently between key support at Rp11,027 and resistance at Rp11,614, with mixed indicator readings - RSI_6 suggests overbought conditions while ADX_6 indicates strong trend strength. With 40% of max supply circulating and average hold time of 31 days, token distribution appears stable.
Outlook remains balanced with technical indicators showing conflicting signals. Key opportunities include potential breakout above Rp11,614 resistance, while risks include overbought RSI conditions and broader crypto market volatility. Investors should monitor volume patterns and ecosystem developments closely.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →